SINARAN

0.065

(%)

MEMORANDUM OF UNDERSTANDING K-Star Sports Limited ("K-Star" or the "Company") - Update on Memorandum of Understanding ("MoU") entered into between Kanger International Berhad ("KIB") and the Company (the "Parties") in relation to the Appointment of K-Star or any one of the subsidiaries of K-Star as the Sale Agent for Covid-19 vaccines in Malaysia

K-STAR SPORTS LIMITED

Type Announcement
Subject MEMORANDUM OF UNDERSTANDING
Description 
K-Star Sports Limited ("K-Star" or the "Company") - Update on Memorandum of Understanding ("MoU") entered into between Kanger International Berhad ("KIB") and the Company (the "Parties") in relation to the Appointment of K-Star or any one of the subsidiaries of K-Star as the Sale Agent for Covid-19 vaccines in Malaysia
 
Unless otherwise stated, all definitions and terms used in this announcement shall carry the same meanings as defined in the previous announcements made by the Company on the MoU on 26 October 2020, 28 October 2020, 11 November 2020, 20 November 2020 and 25 February 2021.

Reference is made to the announcement dated 25 February 2021 pertaining to the MoU made between KIB and K-Star for the purpose of appointing K-Star (or its subsidiary) as the sale agent of Covid-19 vaccines for the private clinics in Malaysia.

The Board of Directors of the Company wishes to inform that it has been notified by KIB that Sinopharm Group Hunan Changde Medical Co., Ltd. has allocated to KIB 10,000 doses of vaccines for trial purpose and that KIB will be responsible for obtaining approval from relevant authorities. The first batch of vaccines is expected to arrive in May 2021.

Any material development will be announced to Bursa Malaysia Securities Berhad in due course.

This announcement is dated 10 March 2021.



Announcement Info

Company Name K-STAR SPORTS LIMITED
Stock Name KSTAR
Date Announced 10 Mar 2021
Category General Announcement for PLC
Reference Number GA1-10032021-00038


View original announcement